Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results

Table 4 Univariate analysis of PFS and OS in our study population

	p value
	mPFS	mOS
Tumor response rate to axitinib
DCR	< 0.0000001	< 0.0000001
ORR	< 0.0000001	0.000026
Tumor response rate to prior sunitinib
DRC	0.00031	0.094
ORR	0.0011	0.049
Duration prior sunitinib treatment ≥ 13.1 vs < 13.1 mo	0.21	0.151
HENG score	0.066	0.002
ECOG PS	0.026	0.003
Prior nephrectomy	0.001	0.000004
G3 blood pressure	0.017	0.017

ISSN: 1479-5876